Application of knockout gene and / or expression gene in preparation of 4-vinylphenol or derivatives thereof

By knocking out the fsc gene in P.putida KT2440 and introducing heterologous expression of phenolic acid decarboxylase and erucic acid decarboxylase, combined with the glycerol tributyrate/water biphasic fermentation system, 4-vinylphenol and its derivatives were solved The problem of cytotoxic inhibition and the simultaneous efficient production of multiple compounds in the production of substances has achieved efficient and environmentally friendly high concentration production.

CN118979053APending Publication Date: 2024-11-19TIANJIN UNIV SYNTHETIC BIOLOGY FRONTIER RES INST
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411111935.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The existing production system of 4-vinylphenol and its derivatives has the problem of production inhibition caused by cytotoxicity, and it is difficult to achieve efficient production of multiple compounds at the same time, and the production process is complex and not environmentally friendly.

Method used

A knockout gene and/or expression gene application was developed, using P.putida KT2440 as the chassis strain, knockout the fsc gene through the CRISPR-Cas9 dual plasmid editing system, and introducing isocarboxylase and erucic acid decarboxylase. Source expression was used to construct an engineering strain that can efficiently produce 4-vinylphenol, 4-vinylguaerosol and 4-vinyl eugenol, and was produced using a tributyrate/water biphasic fermentation system.

Benefits of technology

Achieve high concentration production of 4-vinylphenol, 4-vinyl guaiacol and 4-vinyl eugenol, simplify the production process, overcome cytotoxic inhibition, reduce the complexity of subsequent processes, and the system is environmentally friendly , safe, the initial concentration and purification efficiency of the product are high.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004994490640000061
    Figure BDA0004994490640000061
  • Figure BDA0004994490640000071
    Figure BDA0004994490640000071
  • Figure BDA0004994490640000081
    Figure BDA0004994490640000081
Patent Text Reader

Abstract

The invention relates to the field of bioengineering, in particular to application of a knockout gene and / or an expressed gene in preparation of 4-vinylphenol or a derivative thereof. The invention provides application of a knockout gene and / or an expressed gene in preparation of 4-vinylphenol or a derivative thereof. The knockout gene comprises an fsc gene; the expression gene comprises a gene for coding phenolic acid decarboxylase and / or a gene for coding sinapic acid decarboxylase. The invention develops a high-concentration production system of the 4-vinylphenol derivative so as to meet the market demand, and provides an engineering strain capable of efficiently producing 4-vinylphenol, 4-vinyl guaiacol and 4-vinyl eugenol at the same time so as to simplify the production process; meanwhile, the invention provides a green and environment-friendly double-phase fermentation system which meets the safety requirement of industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of bioengineering, and in particular to the application of knocking out genes and / or expressing genes in the preparation of 4-vinylphenol or its derivatives. Background Art

[0002] The history of human beings using microorganisms to produce the food and drinks they need can be traced back thousands of years. With the rapid development of synthetic biology, the ability to produce target compounds can be given by modularly adjusting and modifying the metabolic processes of microorganisms. The soil bacterium Pseudomonasputida KT2440 has been certified as an environmentally safe, non-pathogenic safe strain. It grows rapidly, has high robustness, and has versatile metabolic capabilities and a wide range of metabolite spectra. These advantages make it one of the laboratory model strains. Therefore, a variety of gene editing tools for P.putida KT2440 have been developed, one of which is a dual-plasmid editing system based on CRISPR-Cas9. The CRISPR / Cas system is an adaptive immune system acquired by bacteria and archaea in long-term evolution to resist the invasion of exogenous DNA, plasmids and bacteriophages. When using this system for gene editing, after cutting the target site, it is induced by arabinose. By utilizing the ability of homologous repair, the two plasmids used are eliminated by rhamnose and sucrose after gene editing, achieving traceless and continuous gene editing. The engineered strains are widely used in the production of high-value compounds, such as polyhydroxyalkanoates, protocatechuic acid, vanillin, etc.

[0003] For the production of 4-vinylphenol, the current production system with a higher yield is developed with Corynebacterium glutamicum as the base bacteria. The base bacteria uses the sacB suicide vector to delete the p-coumaric acid coenzyme A synthetase (phdA) gene, and the phenolic acid decarboxylase from Bacillus amyloliquefaciens is placed under the control of the IPTG-induced Tac promoter for heterologous expression. The constructed engineered bacteria have the ability to convert p-coumaric acid into 4-vinylphenol. In order to overcome the production inhibition caused by the cytotoxicity of 4-vinylphenol, the production system uses undecanol as the organic phase to construct a two-phase fermentation production system with a volume ratio of organic phase to aqueous phase of 1:5. Under this system, with 75g / L p-coumaric acid as the substrate, the titer of 4-vinylphenol in the organic phase reaches 187g / L. For the production of 4-vinylguaiacol, the current production system with a higher yield is a catalytic system obtained by fixing the phenolic acid decarboxylase from Bacillus atrophaeus on zeolite through a connecting peptide. The system finally obtained 295.8 g / L of 4-vinylguaiacol in a 5L bioreactor through batch feeding and toluene extraction strategy. For the production of 4-vinyleugenol, the current high-yield production system is constructed using an engineered enzyme sinapinic acid decarboxylase (SAD) obtained by saturation mutation of the active site. The enzyme was produced at a conversion rate of 99% and an isolated yield of 83% in a two-phase bioreactor containing toluene and 25 g / L sinapinic acid. Summary of the invention

[0004] In view of this, the present invention provides the use of knocking out genes and / or expressing genes in the preparation of 4-vinylphenol or its derivatives. The present invention develops a system for high-concentration production of 4-vinylphenol derivatives to meet market demand. The present invention also provides an engineered strain that can simultaneously and efficiently produce 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol to simplify the production process; at the same time, the present invention provides a green and environmentally friendly dual-phase fermentation system that meets the safety requirements of industrial production.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides the use of knocking out genes and / or expressing genes in preparing 4-vinylphenol or its derivatives;

[0007] The knockout genes include: fsc gene;

[0008] The expressed genes include: a gene encoding phenolic acid decarboxylase and / or a gene encoding sinapinic acid decarboxylase.

[0009] In some embodiments of the present invention, in the above application, the 4-vinylphenol or its derivatives include: one or more of 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol.

[0010] In some embodiments of the present invention, in the above application, the source of the phenolic acid decarboxylase includes: one or more of Lactiplantibacillus plantarum, Conocephalum japonicum, Bacillus licheniformis and / or Bacillus pumilus.

[0011] In some embodiments of the present invention, in the above application, the gene encoding phenolic acid decarboxylase has:

[0012] (1) A nucleotide sequence as shown in any of SEQ ID NO: 1 to SEQ ID NO: 4;

[0013] (2) A nucleotide sequence obtained by modifying, replacing, deleting and / or adding one or more bases to the nucleotide sequence shown in (1);

[0014] (3) a sequence having at least 80% homology with the nucleotide sequence shown in (1);

[0015] (4) A complementary sequence of the sequence shown in (1), (2) or (3).

[0016] In some embodiments of the present invention, in the above application, the sequence of the gene encoding sinapinic acid decarboxylase is shown as SEQ ID NO:5.

[0017] The present invention also provides an expression module, including: expression module 1 and / or expression module 2;

[0018] The expression module 1 includes: the knockout gene described in the above application;

[0019] The expression module 2 includes: the expression gene in the above application.

[0020] In some embodiments of the present invention, in the above expression modules, the expression module 2 comprises: a gene encoding phenolic acid decarboxylase and a gene encoding sinapinic acid decarboxylase derived from Bacillus pumilus.

[0021] In some embodiments of the present invention, in the above expression modules, the expression module 2 further comprises a promoter; the promoter comprises: T3 promoter.

[0022] The present invention also provides a plasmid, comprising: plasmid 1 and / or plasmid 2;

[0023] The plasmid 1 comprises: the expression module 1 in the above expression module;

[0024] The plasmid 2 includes: the expression module 2 in the above expression module.

[0025] The present invention also provides a strain, wherein the plasmid 1 in the above plasmid is transformed and / or transfected into the chassis strain.

[0026] In some embodiments of the present invention, among the above-mentioned strains, the chassis strain includes: Pseudomonas putida.

[0027] In some embodiments of the present invention, among the above-mentioned strains, the chassis strain is: P. putida KT2440.

[0028] The present invention also provides a recombinant strain, in which the plasmid 2 in the above plasmid is transformed and / or transfected.

[0029] The present invention also provides the use of the above expression module, the above plasmid, the above strain and / or the above recombinant strain in the preparation of 4-vinylphenol or its derivatives.

[0030] In some embodiments of the present invention, in the above application, the 4-vinylphenol or its derivatives include: one or more of 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol.

[0031] The present invention also provides a method for preparing 4-vinylphenol or its derivatives, wherein the above strain and / or the above recombinant strain is cultured and fermented in the presence of a substrate to obtain the 4-vinylphenol or its derivatives.

[0032] In some embodiments of the present invention, in the above preparation method, the fermentation uses a fermentation medium; the fermentation medium includes: an aqueous phase and / or an organic phase.

[0033] In some embodiments of the present invention, in the above preparation method, the organic phase comprises: one or more of chloroform, n-pentanol, n-octanol, dibutyl phthalate, isopropyl myristate and tributyrin.

[0034] In some embodiments of the present invention, in the above preparation method, the organic phase comprises: one or more of dibutyl phthalate, isopropyl myristate and tributyrin.

[0035] In some embodiments of the present invention, in the above preparation method, the volume ratio of the organic phase to the aqueous phase is 1:5.

[0036] In some embodiments of the present invention, in the above preparation method, the substrate includes: one or more of p-coumaric acid, ferulic acid and sinapinic acid.

[0037] In some embodiments of the present invention, in the above preparation method, the substrate further comprises: a product of corn stalk hydrolysis.

[0038] In some embodiments of the present invention, in the above preparation method, the strain concentration during fermentation is OD 600 1~5.

[0039] In some embodiments of the present invention, in the above preparation method, the fermentation time is 0 to 72 hours.

[0040] The beneficial effects of the present invention include:

[0041] (1) The microbial production technology system developed by the present invention has currently obtained the highest titers of 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol produced by P.putida KT2440 fermentation, which are 235.3g / L, 202.9g / L and 35.8g / L respectively. And it realizes the one-pot production of 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol, overcoming the problem of lignin heterogeneity. And the system realizes the preliminary concentration and purification of the product, greatly reducing the complexity of the subsequent process, and has the advantages of being environmentally friendly and having high industrial production safety.

[0042] (2) The present invention successfully realizes the one-pot production of 4-vinylphenol and 4-vinylguaiacol from corn stalks. The developed engineered strain can still maintain excellent production performance of 4-vinylphenol derivatives under the harsh conditions of high-concentration lignin hydrolyzate and organic phase. In addition, compared with the traditional production system using glucose as raw material, the production system developed in this study uses corn stalks as precursor, the raw material is cheap and easy to obtain, and the artificially designed metabolic pathway is shorter, and the titer of the obtained 4-vinylphenol derivatives is higher. BRIEF DESCRIPTION OF THE DRAWINGS

[0043] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below.

[0044] Figure 1 The electrophoresis diagram of the fcs gene knockout strain is shown;

[0045] Figure 2 It was shown that phenolic acid decarboxylase catalyzed the conversion of three lignin monomers into 4-vinylphenol derivatives;

[0046] Figure 3The figure shows that the engineered bacteria Plry-6 can efficiently produce 4-vinylphenol and 4-vinylguaiacol; wherein: A shows the concentration change and consumption rate of p-coumaric acid (p-CA); B shows the titer and yield of 4-vinylphenol (4VP); C shows the concentration change and consumption rate of ferulic acid (FA); D shows the titer and yield of 4-vinylguaiacol (4VG);

[0047] Figure 4 The figure shows that the engineered bacteria Plry-7 can efficiently produce 4-vinyleugenol; wherein: A shows the concentration change and consumption rate of sinapinic acid (SA); B shows the titer and yield of 4-vinyleugenol (4VS);

[0048] Figure 5 The figure shows that the engineered bacteria Plry-6 produces 4-vinylphenol under high p-coumaric acid concentration; wherein: A shows the concentration change and consumption rate of p-coumaric acid (p-CA); B shows the titer of 4-vinylphenol (4VP) in the organic phase and the aqueous phase; C shows the yield of 4-vinylphenol; D shows the extraction efficiency of tributyrin for 4-vinylphenol;

[0049] Figure 6 The figure shows that the engineered bacteria Plry-6 produces 4-vinylguaiacol under high ferulic acid concentration; wherein: A shows the concentration change and consumption rate of ferulic acid (FA); B shows the titer of 4-vinylguaiacol (4VG) in the organic phase and the aqueous phase; C shows the yield of 4-vinylguaiacol; D shows the extraction efficiency of tributyrin for 4-vinylguaiacol;

[0050] Figure 7 The one-pot method for producing 4-vinylphenol derivatives by the engineered bacteria Plry-11 is shown; wherein: A shows the concentration change and consumption rate of the aromatic substrate; B shows the titer of the 4-vinylphenol derivative in the organic phase and the aqueous phase; C shows the extraction efficiency of tributyrin for 4-vinylphenol derivatives;

[0051] Figure 8 The figure shows that the engineered bacteria Plry-11 produces 4-vinylphenol and 4-vinylguaiacol in one pot from real lignin hydrolysate; wherein: A shows the concentration changes of p-coumaric acid (p-CA) and ferulic acid (FA); B shows the titer of 4-vinylphenol (4VP) and 4-vinylguaiacol (4VG) in the organic phase; C shows the yield of 4-vinylphenol (4VP) and 4-vinylguaiacol (4VG);

[0052] Fig. 9The figure shows that the engineered bacteria Plry-5 can efficiently produce 4-vinylphenol and 4-vinylguaiacol; wherein: A shows the concentration change and consumption rate of p-coumaric acid (p-CA); B shows the titer and yield of 4-vinylphenol (4VP); C shows the concentration change and consumption rate of ferulic acid (FA); D shows the titer and yield of 4-vinylguaiacol (4VG);

[0053] Fig.10 The figure shows that the engineered bacteria Plry-7 can efficiently produce 4-vinylphenol and 4-vinylguaiacol; wherein: A shows the concentration change and consumption rate of p-coumaric acid (p-CA); B shows the titer and yield of 4-vinylphenol (4VP); C shows the concentration change and consumption rate of ferulic acid (FA); D shows the titer and yield of 4-vinylguaiacol (4VG);

[0054] Fig.11 The figures show that the engineered bacteria Plry-5 and Plry-6 efficiently produce 4-vinyleugenol; wherein: A shows the concentration change of sinapinic acid (SA); B shows the consumption rate of sinapinic acid (SA); C shows the titer of 4-vinyleugenol (4VS); and D shows the yield of 4-vinyleugenol (4VS). DETAILED DESCRIPTION

[0055] The invention discloses the application of knocking out genes and / or expressing genes in preparing 4-vinylphenol or its derivatives.

[0056] It should be understood that the expression "one or more of..." includes each of the items recited after the expression individually and in various different combinations of two or more of the recited items, unless otherwise understood from the context and usage. The expression "and / or" in combination with three or more recited items should be understood to have the same meaning, unless otherwise understood from the context.

[0057] The use of the terms "comprising", "having" or "containing", including their grammatical synonyms, should generally be understood as open and non-restrictive, for example not excluding other unrecited elements or steps, unless otherwise specifically stated or otherwise understood from the context.

[0058] It should be understood that the order of steps or the order in which certain actions are performed is not important as long as the present invention remains operable. In addition, two or more steps or actions may be performed simultaneously.

[0059] The use of any and all examples or exemplary language, such as "for example" or "including", herein is intended only to better illustrate the invention and does not limit the scope of the invention unless otherwise claimed. No language in this specification should be construed as indicating that any non-claimed element is essential to the practice of the invention.

[0060] In addition, the numerical ranges and parameters used to define the present invention are approximate values, and the relevant values ​​in the specific embodiments have been presented as accurately as possible. However, any numerical value inherently inevitably contains standard deviations due to individual test methods. Therefore, unless otherwise expressly stated, it should be understood that all ranges, quantities, values ​​and percentages used in this disclosure are modified by "about". Here, "about" generally means that the actual value is within plus or minus 10%, 5%, 1% or 0.5% of a specific value or range.

[0061] Table 1 Codon-optimized gene sequences of the present invention

[0062]

[0063]

[0064]

[0065] Table 2 Strains and plasmids used in the present invention

[0066]

[0067]

[0068] In Examples 1 to 13 and Effect Examples 1 to 12 of the present invention, the raw materials and reagents used can all be purchased from the market.

[0069] The present invention will be further described below in conjunction with embodiments:

[0070] Example 1

[0071] In order to convert the precursor substances p-coumaric acid and ferulic acid into 4-vinylphenol and 4-vinylguaiacol with maximum flux, it is necessary to block their metabolic pathway in P. putida KT2440 (gift from Nankai University), which is achieved by knocking out the feruloyl-CoA synthetase (fcs) gene using a dual plasmid system.

[0072] First, the plasmid pCAS-RK2T was introduced into the wild-type P.putida KT2440 by electroporation. The specific operation was as follows: pick the activated P.putida KT2440 single colony and inoculate it into LB liquid culture medium, and culture it overnight at 30°C and 180rpm. Then take 2mL of bacterial solution in an EP tube, centrifuge it at 10000rpm for 2min, remove the supernatant, and then resuspend it with sterile 10% glycerol, centrifuge it at 1000rpm for 2min to wash it, wash it 4 times, and then add 90μL of sterile 10% glycerol to resuspend it to prepare Pseudomonas putida competent cells. Add a maximum of 10μL of plasmid pCAS-RK2T to the competent cells, mix it gently, and transfer the entire transformation system to a 1mm electroporation cup, and perform electroporation at a voltage of 1.8kV. After the electroporation operation is completed, 0.9 mL of liquid culture medium is immediately added to the electroporation cup, and the entire system is transferred to a 2 mL EP tube after gentle mixing. Resuscitation is carried out at 30 ° C and 180 rpm for 2.5-3 hours. After the recovery is completed, 100 μL of bacterial solution is evenly spread on a solid agar plate with tetracycline (TE) resistance screening, and cultured overnight in a 30 ° C incubator to obtain the engineered bacteria Plry-0.

[0073] Example 2

[0074] The fcs gene sequence was input into the website rgenome.net / cas-designer / for N20 sequence screening, where the N20 sequence AGGCTGTCGAAGCTTATATG (as shown in SEQ ID NO: 6) can successfully target the target gene. The gene editing results are shown in Figure 1 shown.

[0075] The specific operation is as follows: add BsaⅠ restriction sites at the 3' and 5' ends of the selected N20 sequence, and assemble it with the pSEVA-gRic6T plasmid linearized with BsaⅠ through T4 ligase, react at 16℃ for 2h, and transfer the ligation system into Escherichia coli and culture overnight at 37℃ for 12h. The next day, select a single colony without green fluorescence and culture it in 5mL LB liquid medium containing gentamicin (Gm) to extract the plasmid pSEVA-fcs-N20 containing the N20 sequence, and linearize the plasmid with BamHI and HindⅢ for use. 800bp of homology arms upstream and downstream of the fcs gene were obtained by PCR, and the homology arms and the linearized plasmid pSEVA-fcs-N20 had a 20bp homology sequence. The linearized plasmid, the upper homology arms and the lower homology arms were assembled by the BM seamless cloning kit, followed by colon transformation, and cultured overnight at 37°C for 12h. The successfully assembled bacteria were screened by PCR single colony verification, and cultured overnight in 5mL of LB liquid culture medium containing gentamicin to extract the plasmid pSEVA-lry1 containing the N20 sequence and homology arms for use.

[0076] Example 3

[0077] 400 μL Plry-0 was induced in 10 mL liquid medium containing 6 g / L arabinose and tetracycline for 3 h. After induction, 3 mL of bacterial solution was centrifuged at 10000 rpm for 2 min to harvest the bacteria. Then, it was resuspended with sterile 10% glycerol and washed by centrifugation at 1000 rpm for 2 min. After washing 4 times, 90 μL of sterile 10% glycerol was added and resuspended to prepare competent cells. 10 μL of plasmid pSEVA-fcs-N20-homo was added to the competent cells, and the transformation system was transferred to a 1 mm electroporation cup after gentle mixing, and electroporation was performed at a voltage of 1.8 kV. After the electroporation operation was completed, 0.9 mL of LB liquid medium was immediately added to the electroporation cup, and the system was transferred to a 2 mL EP tube after gentle mixing, and revived at 30 ° C and 180 rpm for 2.5 to 3 h. After recovery, 1 mL of the transformation system was centrifuged at 10,000 rpm for 2 min, 900 μL of the upper supernatant was discarded, and the remaining 100 μL of bacterial solution was evenly spread on a solid agar plate with tetracycline (TE) and gentamicin dual resistance screening, and cultured overnight in a 30°C incubator. The bacteria with successful fcs knockout were screened by PCR single colony verification (such as Figure 1 shown).

[0078] Example 4

[0079] The fcs knockout bacteria obtained in Example 3 were inoculated into 5 mL of liquid culture medium containing tetracycline (TE) and rhamnose (RhaB), and induced at 30°C and 180 rpm for 20 h, so that the plasmid pSEVA-lry1 was eliminated by Cas9. After obtaining a single colony without a TE resistance plasmid, it was inoculated into 5 mL of LB liquid culture medium containing sucrose and glucose, and induced at 30°C and 180 rpm for 20 h to eliminate the plasmid pCAS-RK2T, and obtain the fcs knockout strain Plry-1 without any plasmid.

[0080] Example 5

[0081] A variety of phenolic acid decarboxylases (PADs) were screened from bacteria and plants, including Lactiplantibacillusplantarum (LpPAD), Conocephalumjaponicum (CjPAD), Bacillus licheniformis (BlPAD), Bacilluspumilus (BpPAD) and an engineered enzyme SAD that has been proven to have high catalytic activity for S-type lignin monomer sinapinic acid. The gene was synthesized by Beijing Qingke Biotechnology Co., Ltd. and codon optimized for P. putida KT2440. The gene sequence is shown in Table 1.

[0082] In this study, plasmid pBBR1MCS-2 was used to achieve heterologous expression of various phenolic acid decarboxylases: the PAD gene and plasmid pBBR1MCS-2 were double-digested with HindⅢ and BamHⅠ, and then the linearized plasmid and gene fragments obtained were assembled by T4 ligase, the reaction conditions were 16℃ for 2h, and the ligation system was transferred into Escherichia coli and cultured overnight at 37℃ for 12h. The successfully assembled bacteria were screened by PCR single colony verification, and the successfully assembled plasmid controlled the expression of PAD through the T3 promoter. The expression plasmid containing the PAD gene was cultured overnight in 5mL of LB liquid culture medium containing kanamycin. The plasmid was introduced into Plry-1 by electroporation. The electroporation method was described as above. The plasmids and strains used in the invention are detailed in Table 2. The pathway of phenolic acid decarboxylase catalyzing the synthesis of corresponding 4-vinylphenol derivatives from three lignin monomers is as follows Figure 2 shown.

[0083] Example 6

[0084] The specific operation of preparing the mother liquor of 50g / L lignin monomer p-coumaric acid, ferulic acid and sinapinic acid is as follows: weigh 50g of lignin monomer, dissolve it in 900mL of deionized water, slowly add solid sodium hydroxide under stirring conditions until the lignin monomer is completely dissolved, then slowly adjust the pH of the solution to 7.0 with dilute hydrochloric acid, and dilute to 1L with deionized water. The mother liquor of lignin monomer (except for the use of real lignin hydrolyzate in the following examples, the remaining substrates used in the fermentation are all mother liquor of lignin monomer) is filtered through a 0.22μm water filter membrane for sterilization and set aside.

[0085] Example 7

[0086] In order to explore the ability of each engineered bacteria to produce 4-vinylphenol (4VP), the five engineered bacteria constructed in Example 5 were fermented under the condition of 10mM p-coumaric acid (p-CA). For strain culture, firstly, primary seed culture was carried out: a single colony was picked from the solid agar plate, inoculated into LB liquid culture medium containing 5mL kanamycin, and cultured at 30°C and 220rpm in a shaker for 18h. Then, secondary seed culture was carried out: the primary seed culture was plated at OD 600 The cells were transferred to M9 medium and cultured at 30°C and 220 rpm in a shaker until the OD 600 The final shake flask fermentation was performed: an appropriate amount of secondary seed culture medium was taken and centrifuged at 4000 rpm for 10 min to obtain bacterial cells. The initial OD 600 The fermentation was carried out in a wide-mouth conical flask filled with 50 mL of M9 fermentation medium containing 10 mM p-coumaric acid at 30° C. and 180 rpm.

[0087] The preparation of M9 medium is as follows:

[0088] Stock 1: 67.8 g disodium hydrogen phosphate, 30.0 g potassium dihydrogen phosphate, 5 g sodium chloride, dilute to 1000 mL with deionized water, sterilize with high pressure steam at 121°C for 20 min;

[0089] Stock 2: 1.2 g of anhydrous magnesium sulfate was diluted to 100 mL with deionized water and sterilized by high pressure steam at 121°C for 20 min.

[0090] Stock 3: 10 g of ammonium chloride was diluted to 100 mL with deionized water and sterilized by high pressure steam at 121°C for 20 min.

[0091] Stock4: 110 g of hydrated glucose was diluted to 500 mL with deionized water and sterilized by high pressure steam at 115°C for 15 min;

[0092] Stock5: 1.2g FeSO4·7H2O, 0.54g CaCO3, 0.64g ZnSO4·7H2O; 0.232g MnSO4·H2O, 0.074g CoSO4·7H2O, 0.066g CuSO4·5H2O, 0.016g H3BO3 were dissolved with 1mol / L HCl to 200mL and sterilized by filtration through a 0.22μm filter membrane. Finally, 5mL of Stock1, 1mL of Stock2, 0.5mL of Stock3, 5mL of Stock4, and 5μL of Stock5 were taken and diluted to 50mL with water. By comparing the production performance of 4VP of each engineered bacterium, the engineered bacterium Plry-6 that heterologously expresses BpPAD was selected for subsequent technical development.

[0093] Example 8

[0094] In order to explore the ability of each engineered bacterium to produce 4-vinylguaiacol (4VG), the five engineered bacteria constructed were fermented under the condition of containing 9 mM ferulic acid (FA). The fermentation process is as described in Example 7. By comparing the production performance of 4VG of each engineered bacterium, the engineered bacterium heterologously expressing BpPAD Plry-6 was screened for subsequent technical development.

[0095] Example 9

[0096] In order to explore the ability of each engineered bacterium to produce 4-vinyleugenol (4VS), the five engineered bacteria constructed were used for fermentation under the condition of containing 9mM sinapinic acid (SA). The fermentation process is as described in Example 7. By comparing the production performance of 4VS of each engineered bacterium, the engineered bacterium Plry-7 heterologously expressing SAD was selected for subsequent technical development.

[0097] Example 10

[0098] In order to overcome the inhibitory effects of three 4-vinylphenol derivatives and improve the production performance of engineered bacteria. Six organic reagents were screened as covering layers to extract hydrophobic products, including chloroform, n-pentanol, n-octanol, dibutyl phthalate, isopropyl myristate and tributyrin. The fermentation production steps of 4-vinylphenol derivatives in a two-phase system are as described in Example 7. Only 10 mL of organic phase needs to be added to 50 mL of M9 fermentation medium. The volume ratio of the organic phase to the aqueous phase is 1:5. Organic and aqueous phase samples are taken every 4 hours, and the production time is 12 hours. By comprehensively considering the titer of the obtained 4-vinylphenol derivatives, extraction efficiency, productivity and physicochemical properties of the organic phase, the invention determined the tributyrin / water two-phase system for subsequent technical development.

[0099] Embodiment 11

[0100] In the tributyrin / water biphasic system, 4-vinylphenol and 4-vinylguaiacol were produced using 90 g / L p-coumaric acid and 76 g / L ferulic acid as substrates, respectively. In order to maximize the conversion of aromatic substrates, the engineered strain Plry-6 expressing BpPAD was grown at an initial OD of 600 For 5 access fermentation.

[0101] Example 12

[0102] In a tributyrin / water biphasic system, 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol were produced in one pot using 60 g / L p-coumaric acid, 15 g / L ferulic acid and 15 g / L sinapic acid as substrates. In order to maximize the simultaneous conversion of these three lignin substrates, BpPAD and SAD were assembled into the same expression plasmid, and the specific operation was as follows: pBBR1-SAD plasmid was digested with BamHI and the linearized plasmid was obtained. At the same time, the BpPAD gene fragment with 20bp homology arms upstream and downstream of the BamHⅠ restriction site of the plasmid was obtained and linearized by PCR using Q5 High-Fidelity2XMasterMix, and then assembled using the BM seamless cloning kit, followed by colon transformation, overnight culture at 37°C for 12 hours, and the successfully assembled bacteria were screened by PCR single colony verification, and cultured overnight in 5mL LB liquid culture medium containing kanamycin and the plasmid was extracted. In the plasmid, BpPAD and SAD were simultaneously expressed under the control of the T3 promoter, and the plasmid was electrotransfected into Plry-1 to obtain the engineered bacteria Plry-11. The obtained engineered bacteria Plry-11 was isolated at an initial OD 600 The production was carried out by 5 access fermentation.

[0103] Example 13

[0104] In a tributyrin / water biphasic system, 4-vinylphenol and 4-vinylguaiacol were produced in a one-pot process using real lignin hydrolysate as substrate.

[0105] The preparation of lignin hydrolyzate for bioconversion is as follows: corn stalks from Tianjin Rubber Area, China are washed three times to remove dust, sludge and other impurities, and then placed in a 60°C oven to dry to a moisture content of about 5wt%. The dried corn stalks are then ground and sieved to collect corn stalk powder with a particle size range of 0.18mM to 0.85mM. The stalks are then pretreated with sodium hydroxide. 1g of sodium hydroxide is dissolved in 90mL of deionized water to prepare a sodium hydroxide solution, which is added to a pretreatment reactor containing 10g of stalks and mixed evenly. The pretreatment reactor is then placed in an oil bath, heated to 130°C, and reacted for 30min. After the reaction is completed, the material is filtered through four layers of gauze to obtain an alkaline treatment solution, the pH is adjusted to 7, and then freeze-dried and sterilized at 115°C for 15 minutes to obtain a dry powder with soluble lignin as the main component as a fermentation precursor. 5 g of sterile lignin dry powder was added to 50 mL of M9 medium to prepare a 100 g / L lignin fermentation medium. In order to maintain high production performance in this high salt ion system, the initial OD of the engineered bacteria Plry-11 was 600 Set to 5 for production.

[0106] Effect Example 1

[0107] Phenolic acid decarboxylase BpPAD, which can efficiently catalyze the decomposition of lignin H-type monomers (p-coumaric acid) and G-type monomers (ferulic acid), was screened out and expressed in the bottom fungus P. putida KT2440. The constructed engineered bacterium Plry-6 can achieve efficient microbial production of 4-vinylphenol and 4-vinylguaiacol: when 10.5mM p-coumaric acid (p-CA) was used as the substrate, most of the substrate was consumed, and the titer of 4-vinylphenol (4VP) reached a maximum of 9.4mM at 12h of fermentation, with a molar yield of 92.6% (as shown in Figure 2). Figure 3 and Table 3); when 8.8 mM ferulic acid (FA) was used as the substrate, the engineered bacteria completely consumed the substrate, and the titer of 4-vinylguaiacol reached a maximum of 7.5 mM at 24 h of fermentation, with a molar yield of 85.4% (as shown in ... Figure 3 and Table 4).

[0108] Table 3 Fermentation parameters of engineering bacteria Plry-6 producing 4-vinylphenol

[0109]

[0110] p-CA: p-coumaric acid; 4VP: 4-vinylphenol.

[0111] Table 4 Fermentation parameters of engineered bacteria Plry-6 producing 4-vinylguaiacol

[0112]

[0113] FA: ferulic acid; 4VG: 4-vinylguaiacol.

[0114] Effect Example 2

[0115] The phenolic acid decarboxylase SAD that can efficiently catalyze the S-type monomer of lignin (sinapic acid) was screened and expressed in the bottom fungus P. putida KT2440. The engineered bacteria Plry-7 constructed can achieve efficient microbial production of 4-vinyleugenol. When fermented under the condition of sinapic acid concentration of 8.6mM, the engineered bacteria Plry-7 heterologously expressing SAD completely consumed sinapic acid after 48h of fermentation, accumulated 5.2mM 4-vinyleugenol (4VS), and the molar yield was 62.6% (as shown in Figure 2). Figure 4 and Table 5).

[0116] Table 5 Fermentation parameters of engineered bacteria Plry-7 producing 4-vinyleugenol

[0117]

[0118]

[0119] SA: sinapinic acid; 4VS: 4-vinyleugenol.

[0120] Effect Example 3

[0121] A two-phase fermentation system, namely the tributyrin / water two-phase system, was constructed to efficiently achieve in-situ separation of products. This system solves the toxic effects of continuous contact between the product and the cell factory, and achieves high substrate, high productivity and high extraction efficiency production of three 4-vinylphenol products. When 7g / L p-coumaric acid (p-CA) was used as a substrate and Plry-6 was used for production, the substrate consumption rate in the single aqueous system was only 72.1% due to the inhibition of the product, and the titer of 4-vinylphenol (4VP) was 3.1g / L; while in the tributyrin / water two-phase system, the substrate consumption rate was as high as 99.7%, the titer of 4-vinylphenol in the organic phase was 24.3g / L, the corresponding yield was 98.6%, the extraction rate of tributyrin was 87.5%, and the productivity in 8h was 3.0g / L / h. When Plry-6 was used for production with 8 g / L ferulic acid (FA) as the substrate, the substrate consumption rate in the single aqueous phase system was only 60.3% in 8 hours, and the titer of 4-vinylguaiacol (4VG) was 3.1 g / L; while in the tributyrin / water two-phase system under the same production conditions, the substrate consumption rate was as high as 88.5%, the titer of 4-vinylguaiacol in the organic phase was 21.6 g / L, the corresponding yield was 84.3%, the extraction efficiency of tributyrin was 91.6%, and the productivity of 8 hours fermentation was 2.7 g / L / h. When 9 g / L sinapinic acid (SA) was used as the substrate for production using Plry-7, the consumption rate of the substrate in the single aqueous phase in 48 h was only 72.3%, and the titer of 4-vinyl eugenol (4VS) was 3.1 g / L; while in the tributyrin / water two-phase system, the titer of 4-vinyl eugenol in the organic phase was 35.8 g / L, the corresponding yield was 99.9%, and the extraction efficiency of tributyrin was 96.0% (Table 6). In addition, tributyrin has low solubility in the aqueous phase and high boiling point, so during the production process, the volume lost in the aqueous phase and gas phase is very small. At the same time, the production process of 4-vinyl phenol derivatives is carried out in the presence of air, so the saturated vapor pressure, flash point and explosiveness of the medium in the production system are important parameters to be considered. Tributyrin has a lower saturated vapor pressure and a higher flash point, which greatly reduces the risk of fire and greatly improves the safety of downstream processes. In addition, tributyrin has less harm to the environment, safety and health.

[0122] Table 6 Effect of tributyrin / water biphasic system on the production of three 4-vinylphenol derivatives

[0123]

[0124]

[0125] p-CA: p-coumaric acid; FA: ferulic acid; SA: sinapinic acid; 4VP: 4-vinylphenol; 4VG: 4-vinylguaiacol; 4VS: 4-vinyleugenol.

[0126] Effect Example 4

[0127] In the tributyrin / water biphasic system, Plry-6 was used to produce 4-vinylphenol at a high p-coumaric acid substrate concentration (90.3 g / L). After 12 h, the titer in the organic phase reached 235.3 g / L, and 95.2% of 4-vinylphenol was extracted into the organic phase and separated from the aqueous phase. The yield was 84.8%, which represents the highest titer produced by P. putida KT2440 fermentation (such as Figure 5 and Table 7).

[0128] Table 7 Engineering bacteria Plry-6 produces 4-vinylphenol under high p-coumaric acid concentration.

[0129]

[0130] p-CA: p-coumaric acid; 4VP: 4-vinylphenol

[0131] Effect Example 5

[0132] In the tributyrin / water biphasic system, Plry-6 was used to produce 4-vinylguaiacol at a high ferulic acid substrate concentration (76.1 g / L). After 12 h, the titer in the organic phase reached 202.9 g / L. The extraction efficiency of this biphasic system for 4-vinylguaiacol was 91.7%, and the yield was 97.9%, representing the highest titer produced by P. putida KT2440 fermentation (e.g. Figure 6 and Table 8).

[0133] Table 8 Production of 4-vinylguaiacol by engineered bacteria Plry-6 at high ferulic acid concentration

[0134]

[0135]

[0136] FA: Ferulic acid; 4VG: 4-vinylguaiacol

[0137] Effect Example 6

[0138] In a tributyrin / water biphasic system, Plry-11 was used to produce 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol in one pot for the first time using p-coumaric acid (63.7 g / L), ferulic acid (15.9 g / L) and sinapinic acid (12.6 g / L) as substrates, and the titers in the organic phase reached 149.6 g / L (Table 9), 46.9 g / L (Table 10) and 14.9 g / L (Table 11), respectively. In addition, the extraction efficiencies of tributyrin for 4-vinylphenol, 4-vinylguaiacol and 4-vinyleugenol were 96.6%, 98.2% and 99.0%, respectively (Table 11). Figure 7 shown).

[0139] Table 9 Parameters of the one-pot production of engineered bacteria Plry-11 to convert H-type lignin monomer p-coumaric acid into 4-vinylphenol

[0140]

[0141] Table 10 Parameters of the engineering bacteria Plry-11 in the one-pot production of ferulic acid, a monomer of G-type lignin, to 4-vinylguaiacol

[0142]

[0143] Table 11 Parameters of the engineering bacteria Plry-11 in the one-pot production of S-type lignin monomer sinapinic acid to 4-vinyleugenol

[0144]

[0145] Effect Example 7

[0146] The invention uses an alkali-catalyzed method to separate and depolymerize lignin from corn stalks. The main component of the hydrolyzate obtained by this method is soluble lignin, which is suitable for microbial transformation. The initial concentrations of p-coumaric acid and ferulic acid in the lignin fermentation medium are 3.4 g / L and 0.7 g / L, respectively (Table 12). After 12 hours of fermentation, p-coumaric acid and ferulic acid are completely consumed. At the same time, the titers of 4-vinylphenol and 4-vinylguaiacol in the organic phase are 12.4 g / L and 2.3 g / L, respectively, and the corresponding yields are 99.9% and 99.6%, respectively (Table 12). Figure 8 and Table 12).

[0147] Table 12 One-pot production of 4-vinylphenol and 4-vinylguaiacol from real lignin hydrolysate by engineered bacteria Plry-11

[0148]

[0149] p-CA: p-coumaric acid; FA: ferulic acid; 4VP: 4-vinylphenol; 4VG: 4-vinylguaiacol.

[0150] Effect Example 8

[0151] The engineered strain Plry-5 heterologously expressing BlPAD developed by the invention can also efficiently catalyze the decarboxylation of p-coumaric acid and ferulic acid to generate 4-vinylphenol and 4-vinylguaiacol, respectively: when 10.5 mM p-coumaric acid (p-CA) is used as the substrate, most of the substrate is consumed, and the titer of 4-vinylphenol (4VP) reaches a maximum of 9.2 mM at 12 h of fermentation, with a molar yield of 91.1% (e.g. Fig. 9 and Table 13); when 8.8 mM ferulic acid (FA) was used as the substrate, the engineered bacteria completely consumed the substrate, and the titer of 4-vinylguaiacol reached a maximum of 7.5 mM at 24 h of fermentation, with a molar yield of 85.2% (as shown in ... Fig. 9 and Table 14).

[0152] Table 13 Fermentation parameters of engineering bacteria Plry-5 producing 4-vinylphenol

[0153]

[0154] p-CA: p-coumaric acid; 4VP: 4-vinylphenol.

[0155] Table 14 Fermentation parameters of engineering bacteria Plry-5 producing 4-vinylguaiacol

[0156]

[0157] FA: ferulic acid; 4VG: 4-vinylguaiacol.

[0158] Effect Example 9

[0159] The engineered strain Plry-7 that heterologously expresses SAD can also efficiently catalyze the decarboxylation of p-coumaric acid and ferulic acid to generate 4-vinylphenol and 4-vinylguaiacol, respectively: when 10.5 mM p-coumaric acid (p-CA) is used as a substrate, most of the substrate is consumed, and the titer of 4-vinylphenol (4VP) reaches a maximum of 8.5 mM at 48 h, with a molar yield of 90.0% (e.g. Fig.10 and Table 15); when 8.8 mM ferulic acid (FA) was used as the substrate, the engineered bacteria Plry-7 completely consumed the substrate, and the titer of 4-vinylguaiacol reached a maximum of 7.3 mM at 72 h of fermentation, with a molar yield of 84.4% (as shown in ... Fig.10 and Table 16).

[0160] Table 15 Fermentation parameters of engineering bacteria Plry-5 producing 4-vinylphenol

[0161]

[0162] p-CA: p-coumaric acid; 4VP: 4-vinylphenol.

[0163] Table 16 Fermentation parameters of engineering bacteria Plry-5 producing 4-vinylguaiacol

[0164]

[0165] FA: ferulic acid; 4VG: 4-vinylguaiacol.

[0166] Effect Example 10

[0167] The engineered bacteria Plry-5 and Plry-6 heterologously expressing BpPAD developed by the invention can also efficiently catalyze the decarboxylation of sinapinic acid to produce 4-vinyleugenol: when fermented under the condition of a sinapinic acid concentration of 8.6 mM, Plry-5 and Plry-6 consumed 56.0% and 50.5% of the substrate, respectively, within 48 h, and the corresponding titers of 4-vinyleugenol were 2.9 mM and 3.0 mM, respectively, and the molar yields were 60.0% and 70.2%, respectively (e.g. Fig.11 ).

[0168] Table 17 Engineering bacteria Plry-5 produces 4-vinyleugenol.

[0169]

[0170] SA: sinapinic acid; 4VS: 4-vinyleugenol.

[0171] Table 18 Engineering bacteria Plry-6 produces 4-vinyleugenol.

[0172]

[0173] SA: sinapinic acid; 4VS: 4-vinyleugenol.

[0174] Effect Example 11

[0175] The performance summary of the invented engineered bacteria Plry-5, Plry-6 and Plry-7 in producing three 4-vinylphenol derivatives is shown in Table 19.

[0176] Table 19 Performance of different engineered bacteria in producing 4-vinylphenol derivatives.

[0177]

[0178] p-CA: p-coumaric acid; FA: ferulic acid; SA: sinapinic acid; 4VP: 4-vinylphenol; 4VG: 4-vinylguaiacol; 4VS: 4-vinyleugenol.

[0179] Effect Example 12

[0180] The invented dibutyl phthalate / water two-phase system and isopropyl myristate / water two-phase system can also relieve the inhibitory effect of the product and promote the production of three 4-vinylphenol derivatives. The specific fermentation performance parameters are shown in Table 20.

[0181] Table 20 Fermentation parameters for production of different biphasic systems.

[0182]

[0183] T4VP: titer of 4-vinylphenol; T4VG: titer of 4-vinylguaiacol; T4VS: titer of 4-vinyleugenol; Y4VP: yield of 4-vinylphenol; Y4VG: yield of 4-vinylguaiacol; Y4VS: yield of 4-vinyleugenol; E4VP: extraction efficiency of 4-vinylphenol; E4VG: extraction efficiency of 4-vinylguaiacol; E4VS: extraction efficiency of 4-vinyleugenol.

[0184] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. Application of knockout genes and / or expressed genes in the preparation of 4-vinylphenol or its derivatives; The knockout genes include: fsc gene; The expressed genes include: a gene encoding phenolic acid decarboxylase and / or a gene encoding sinapinic acid decarboxylase.

2. The use according to claim 1, characterized in that The source of the phenolic acid decarboxylase includes: one or more of Lactiplantibacillus plantarum, Conocephalum japonicum, Bacillus licheniformis and / or Bacillus pumilus.

3. The use according to claim 1 or 2, characterized in that: The gene encoding phenolic acid decarboxylase has: (1) A nucleotide sequence as shown in any of SEQ ID NO: 1 to SEQ ID NO: 4; (2) A nucleotide sequence obtained by modifying, replacing, deleting and / or adding one or more bases to the nucleotide sequence shown in (1); (3) a sequence having at least 80% homology with the nucleotide sequence shown in (1); (4) A complementary sequence of the sequence shown in (1), (2) or (3).

4. An expression module, characterized in that include: Expression module 1 and / or expression module 2; The expression module 1 comprises: the knockout gene as described in any one of claims 1 to 3; The expression module 2 includes: the expression gene in the application according to any one of claims 1 to 3.

5. A plasmid, characterized in that include: Plasmid 1 and / or plasmid 2; The plasmid 1 comprises: the expression module 1 in the expression module according to claim 4; The plasmid 2 comprises: the expression module 2 in the expression module according to claim 4.

6. A strain characterized in that The plasmid 1 in the plasmid according to claim 5 is transformed and / or transfected into a chassis strain.

7. A recombinant strain, characterized in that The plasmid 2 in the plasmid according to claim 5 is transformed and / or transfected into the strain according to claim 6.

8. Use of the expression module according to claim 4, the plasmid according to claim 5, the strain according to claim 6 and / or the recombinant strain according to claim 7 in the preparation of 4-vinylphenol or its derivatives.

9. A method for preparing 4-vinylphenol or a derivative thereof, characterized in that: The strain according to claim 6 and / or the recombinant strain according to claim 7 is cultured and fermented in the presence of a substrate to obtain the 4-vinylphenol or its derivatives.

10. The preparation method according to claim 9, characterized in that: The fermentation uses a fermentation medium; the fermentation medium includes: an aqueous phase and / or an organic phase.

Citation Information

Cited By

  • Bacillus sorola and application thereof

    CN120330100A

  • A p-coumarate decarboxylase mutant and its use in producing p-hydroxystyrene

    CN122790911A